| scholarly article | Q13442814 |
| P356 | DOI | 10.1371/JOURNAL.PONE.0182187 |
| P953 | full work available at URL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546579 |
| P932 | PMC publication ID | 5546579 |
| P698 | PubMed publication ID | 28787025 |
| P50 | author | Mats Wahlgren | Q6228900 |
| Chiaka I. Anumudu | Q55175750 | ||
| James Beeson | Q56780488 | ||
| Linda Reiling | Q118533572 | ||
| P2093 | author name string | Christine Langer | |
| Roseangela I Nwuba | |||
| Adanze O Asinobi | |||
| Michael C Asuzu | |||
| Olajumoke A Morenikeji | |||
| Kristina E M Persson | |||
| Alex B Odaibo | |||
| Muyideen K Tijani | |||
| Oluwatoyin A Babalola | |||
| P2860 | cites work | Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum | Q24297064 |
| A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin A | Q24643787 | ||
| Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria | Q26772878 | ||
| Abnormal PfEMP1/knob display on Plasmodium falciparum-infected erythrocytes containing hemoglobin variants: fresh insights into malaria pathogenesis and protection | Q27027956 | ||
| A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes | Q27230006 | ||
| A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites | Q27230065 | ||
| Young lives lost as B cells falter: what we are learning about antibody responses in malaria | Q27687235 | ||
| Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbits | Q28742130 | ||
| Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl) | Q30042536 | ||
| Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand | Q30043671 | ||
| Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria | Q31169310 | ||
| Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum | Q33380204 | ||
| The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis | Q33526349 | ||
| Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum | Q33591313 | ||
| Immune evasion strategies of pre-erythrocytic malaria parasites. | Q33661539 | ||
| Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial | Q34043843 | ||
| Variation in the expression of a Plasmodium falciparum protein family implicated in erythrocyte invasion | Q34131763 | ||
| Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic | Q34189972 | ||
| An expanding ebl family of Plasmodium falciparum | Q34264741 | ||
| The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria. | Q34428497 | ||
| Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies | Q34680704 | ||
| Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites | Q34739631 | ||
| Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum | Q34988452 | ||
| Genetic diversity of Plasmodium falciparum among school-aged children from the Man region, western Côte d'Ivoire | Q35042596 | ||
| Protection of Malian children from clinical malaria is associated with recognition of multiple antigens | Q35094826 | ||
| The 10 kDa domain of human erythrocyte protein 4.1 binds the Plasmodium falciparum EBA-181 protein | Q35129141 | ||
| Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria | Q35213495 | ||
| Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western Kenya | Q35550197 | ||
| Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175. | Q35557657 | ||
| Variation in Plasmodium falciparum erythrocyte invasion phenotypes and merozoite ligand gene expression across different populations in areas of malaria endemicity | Q35609283 | ||
| Genetic evidence for contribution of human dispersal to the genetic diversity of EBA-175 in Plasmodium falciparum | Q35908103 | ||
| Analysis of erythrocyte invasion mechanisms of plasmodium falciparum clinical isolates across 3 malaria-endemic areas in Ghana | Q36078771 | ||
| Strategies to alleviate original antigenic sin responses to influenza viruses | Q36187304 | ||
| Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies | Q36227228 | ||
| New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women | Q36330969 | ||
| Factors determining the occurrence of submicroscopic malaria infections and their relevance for control | Q36503207 | ||
| Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific | Q36539692 | ||
| Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
| Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development | Q36984161 | ||
| Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1 | Q37146848 | ||
| Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity | Q37202344 | ||
| Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children | Q37220749 | ||
| Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum | Q37643916 | ||
| Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum | Q37969486 | ||
| Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes | Q38321747 | ||
| Dynamics of the antibody response to Plasmodium falciparum infection in African children | Q39589730 | ||
| Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria | Q40913951 | ||
| Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. | Q41460430 | ||
| Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus | Q41874514 | ||
| Entomological indices of Anopheles gambiae sensu lato at a rural community in south-west Nigeria. | Q44145773 | ||
| Studies on Plasmodium falciparum parasitemia and development of anemia in Nigerian infants during their first year of life. | Q46363696 | ||
| Variation in the relationship between anti-MSP-1(19) antibody response and age in children infected with Plasmodium falciparum during the dry and rainy seasons | Q46784544 | ||
| EBL-1, a putative erythrocyte binding protein of Plasmodium falciparum, maps within a favored linkage group in two genetic crosses | Q47897125 | ||
| Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia | Q47954510 | ||
| Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria | Q47957417 | ||
| Gamma-globulin and acquired immunity to human malaria | Q47957467 | ||
| Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte | Q47970034 | ||
| 'Original antigenic sin', T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasion | Q48002588 | ||
| Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting | Q48028402 | ||
| Immune effector mechanisms in malaria | Q82383609 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| evasion of host immune response | Q1660157 | ||
| P304 | page(s) | e0182187 | |
| P577 | publication date | 2017-08-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Acquisition, maintenance and adaptation of invasion inhibitory antibodies against Plasmodium falciparum invasion ligands involved in immune evasion | |
| P478 | volume | 12 |
| Q55248535 | Factors influencing the induction of high affinity antibodies to Plasmodium falciparum merozoite antigens and how affinity changes over time. | cites work | P2860 |
Search more.